Rectal Cancer Case Study

and rectum cancer is ranked third for cancer incidence and fourth for cancer death globally in 2013. Further colon and rectum cancer ranked second for incidence and mortality for developed countries and ranked fourth for both incidence and mortality for developing countries. The Global burden of cancer study showed that colon and rectal cancer was the fourth leading cause for cancer related years life lost between 1990 and 2013. The number of people diagnosed with colon and rectal cancer doubled from

Beginning of shift: FULL CODE -The patient is a 70 -year- old male with stage IV rectal cancer, currently being treated with chemotherapy for the past 6 months. The patient came to the ER with a 3 -day history of worsening abdominal pain. The patient’s weight is 116 pounds and the is height 5 feet and 7 inches. The patient states pain on a scale from 0 to 10 at a 4. The patient has no fever but states that he is cold. No sore throat. No chest pain or palpitations are reported. There is no nausea

Review of the medical record indicates that she was diagnosed with stage 3 rectal cancer with Mets to bones in 2013 for which she was treated with radiation treatments. She is followed by Dr Lederman in New York and locally by Dr patel- oncologist. After her radiation therapy she developed lymphedema to left lower extremity. She is follow by healthy lymphatics agency and was been followed by Dr DeBonet for pain. At today’s visit she is awake, alert and oriented times 3. She reports that she was been

MR imaging has been shown to be a useful tool for the assessment of both rectal and anal cancers [3,7–12]. However, its role in differentiating the site of origin of carcinomas that overlap the anorectal junction is limited, as most of the cases need histological confirmation for a final diagnosis. The American Joint Committee on Cancer recommends that if the epicenter of the tumor is located more than 2 cm proximal to the dentate line or proximal to the anorectal ring on digital examination, defined

department Abstract: Background: proper rectal cancer staging is a vital step in management and prognosis of the disease depending on the tumour, nodal state and distant metastasis (TNM). Sufficient number of lymph nodes detected in postoperative TME specimen is a corner stone in staging. Lymph node number detected should not be less than 12 lymph nodes. Material and methods: 37 Egyptian patients diagnosed with rectal carcinoma were included in this retrospective study. 28 patients received neoadjuvant

Colorectal carcinoma (CRC) is one of the lethal malignant diseases and is the third most common cancer and the fourth most common cause of cancer deaths worldwide. It is the third most common cancer in men (10% of all cancers in men worldwide) and second most in women (9.2% of all cancers in women worldwide)(1). It is a slow developing cancer that begins as a tumor or a tissue growth on the inner lining of the large bowel. The most common type of CRC is adenocarcinoma (more than 95%)(2). Even with

Introduction According to the American Cancer Society, nearly 161,360 new cases of prostate cancer are expected to be diagnosed with an estimated 26,730 prostate-cancer specific deaths in 2017. Prostate cancer is the third leading cause of cancer death in American men, behind lung and colorectal cancer. Current available treatments for prostate cancer include active surveillance, surgery, radiation therapy (external beam or/and brachytherapy), cryosurgery, hormone therapy, chemotherapy, vaccine

Introduction This report will use the case of a patient diagnosed with rectal cancer to examine the psychological, sociological and public health issues associated with such patients, as well as to discuss the rationale of therapeutic interventions used. Section A: Case History Mrs. SH is an 83-year-old retired Caucasian school teacher with a BMI of 22.9kg/m2. She presented to her GP on 7 February 2014 with a six-week history of diarrhoea. She described having “tanned, sandy, loose” stools and a

absence of a detectable primary cancer (after investigation) is termed cancer of unknown primary or CUP (1). CUP comprises 2-6% of all malignancies (1), and is generally divided further based on the site of the metastasis and prognosis (2). Most cases are carcinomas with adenocarcinomas (undifferentiated to well differentiated) accounting for 90%, squamous cell carcinomas (SCC) making up 5% and undifferentiated neoplasm accounting for the remainder (3). In post-mortem studies, the primary tumor was discovered

of Transanal Total Mesorectal Excision Compared to Laparoscopic Surgery for the treatment of middle and lower rectal cancers: A Case-Control study Objective: we are trying to evaluate the clinical and pathological results of an open transanal TME plus laparoscopic abdominal approach in comparison with the conventional LapTME for surgical management of lower and middle third rectal cancer. Introduction The rectum is defined as the part of the bowel that extend from the anal verge up to fifteen